Advertisement
Advertisement
FATE
Fate Therapeutics, Inc.
1.39
USDSponsored
+0.02
+1.46%
Apr 17, 15:32 UTC -4
Closed
After-Market
1.40
+0.01
+0.36%
Fate Therapeutics, Inc. Financial Snapshot
| Market Cap | 162.19M |
| Beta | 2.23 |
| Earnings Per Share (EPS) | -1.15 |
| Price-to-Book (P/B) Ratio | 0.71 |
| Operating Margin | -2051.08% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -55.02% |
| Current Ratio | 5.79% |
| Free Cash Flow | -111.67M |
Trending Stocks
Advertisement